Menu
About
Overview
Values
Management
Board of Directors
Social Community Guidelines
Pipeline
Overview
Voxelotor for Sickle Cell Disease
Patients
GBT's Commitment
About Sickle Cell Disease
Investigational Medicines
Stay Informed
Investors
Investor Overview
Press Releases
Events & Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Investor FAQs
E-mail Alerts
IR Contact
Media
Careers
Contact
About
Values
Our Purpose
To revolutionize the treatment of grievous blood-based conditions
Core Values
Science dedicated to patients
Embrace open communication and debate
Trust, respect, and accountability
One team, one purpose
...always do the right thing